SCR-LIP-000407 · Claim · machine-readable JSON →

In a study of PBMT applied before dermolipectomy in three lipedema patients, the article notes that lipedema predominantly affects women during hormonal phases (menarche, pregnancy, menopause) and reports laser-induced upregulation of aromatase (CYP1A1), a hemoprotein involved in hormone metabolism, without directly testing hormonal or hereditary causes of onset.

Claim at a glance

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-07-12

Evidence over time

Lasers in Medical Science (2025) 40:437 (2025) ✓ verified — contextual · case series · 2025 · reading confidence: high
“it predominantly affects women during specific hormonal phases such as menarche, pregnancy and menopause”
The abstract mentions the hormonal-phase predominance as background and reports aromatase changes, but the study tests a laser therapy's tissue effects, not the hormonal or hereditary etiology of lipedema onset, so it is on-topic context ra

Populationthree women with lipedema undergoing dermolipectomy

Conditionlipedema

Exposurephotobiomodulation therapy (red/infrared LED)

Comparatornon-irradiated contralateral side

Outcomeadipocyte size, apoptosis, inflammatory markers, aromatase (CYP1A1) expression

Scopeauto-ingested from Layer 1 surveillance

Auto-ingested single source; not yet human-reviewed.